Source BioScience UK has acquired clinical healthcare testing service provider Cambridge Clinical Laboratories (CCL), enhancing its clinical diagnostics portfolio. The acquisition enables Source ...
Source BioScience UK Ltd, announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL). The acquisition bolsters the Company’s clinical diagnostics portfolio by leveraging the ...
Source BioScience’s GenomeCube includes 20 million clones and antibodies. Source BioScience and DNAFORM are launching the Japanese version of Source BioScience’s GenomeCube® database and webstore.
The £63m sale of Nottingham-based laboratory services provider Source BioScience has moved closer. On Friday, the firm's shareholders voted in favour of the sale to Sherwood Holdings, which was ...
19 January 2012 NOTTINGHAM, England -(BUSINESS WIRE/ME NewsWire)-- Source BioScience plc (LSE: SBS) ("Source BioScience" or the "Company"), the international diagnostic and genetic analysis business, ...
Adjusted* EBITDA increased by 13% to £5.8 million (2014: £5.1 million) Adjusted* profit before tax increased by 15% to £3.3 million (2014: £2.8 million) Profit before tax up 40% to £2.0 million (2014: ...
NOTTINGHAM, England, April 23, 2020 /PRNewswire/ -- Source BioScience Limited, a highly accredited ISO:15189:2012 international laboratory services provider, has rapidly developed a robust COVID-19 ...
Source BioScience Limited is an international provider of integrated state of the art Laboratory Services and Products. Headquartered in the UK, with offices in UK, Europe and the USA, Source ...
LONDON (Alliance News) - Two private investment management firms on Friday said they are considering making an offer to acquire Source BioScience PLC, adding the offer price would be at a premium to ...
Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results